Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Nov 29;65(12):2126-2129.
doi: 10.1093/cid/cix613.

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program

Affiliations
Observational Study

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program

Tafese Beyene et al. Clin Infect Dis. .

Abstract

A total of 817 human immunodeficiency virus-infected Ethiopians with CD4 <150 cells/mL underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of participants with plasma CRAG titers >1:640, 96% (27 of 28) had cryptococcal meningitis (cerebrospinal fluid CRAG-positive) whereas 50% (7 of 14) with 1:160-1:320 titers had meningitis. With fluconazole 1200 mg/d therapy, 68% of meningitis patients (23 of 34) died within 3 months. Plasma CRAG titers >1:160 predict meningitis, requiring more intensive antifungal therapy.

Keywords: Cryptococcal meningitis /PC; Cryptococcosis /PC; Cryptococcus; Ethiopia; Fluconazole; Mass Screening; Prevention & Control.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A, Plasma cryptococcal antigen (CrAg) by lateral flow assay (LFA) titer versus cerebrospinal fluid (CSF) CrAg positivity. In 5 patients who declined lumbar puncture (LP), CSF results were imputed based on clinical symptoms. Two patients were asymptomatic with plasma titers ≤1:80, and 3 had symptomatic meningitis with headache (n = 3) and/or altered mental status (n = 2). Among patients with plasma CrAg titers from 1:160 to 1:640, 65% (13 of 20) were CSF positive, including 7 of 8 with a titer of 1:640. B, Matrix plot of CD4+ T-cell count versus plasma CrAg titer and CSF positivity or negativity.

References

    1. Rajasingham R, Smith RM, Park BJ et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017. doi:10.1016/S1473-3099(17)30243-8. - PMC - PubMed
    1. Meya DB, Manabe YC, Castelnuovo B et al. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count ≤100 cells/μL who start HIV therapy in resource-limited settings. Clin Infect Dis 2010; 51:448–55. - PMC - PubMed
    1. Letang E, Muller MC, Ntamatungiro AJ et al. Cryptococcal antigenemia in immunocompromised HIV patients in rural Tanzania: a preventable cause of early mortality. Open Forum Infect Dis 2015; 2:ofv046. - PMC - PubMed
    1. Mfinanga S, Chanda D, Kivuyo SL et al. ; REMSTART trial team Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet 2015; 385:2173–82. - PubMed
    1. Longley N, Jarvis JN, Meintjes G et al. Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study. Clin Infect Dis 2016; 62:581–7. - PMC - PubMed

Publication types

MeSH terms